Back
Zoetis Vs. Biomarin Pharmaceutical Industry Stock Comparison
Buy
56
ZTS
Zoetis
Last Price:
192.56
Seasonality Move:
4.01%
Sell
35
BMRN
Biomarin Pharmaceutical
Last Price:
70.70
Seasonality Move:
5.7%
Buy
56
Zoetis (ZTS)
is a Buy
Is Zoetis a Buy, Sell or Hold?
- The current Zoetis [ZTS] share price is $192.64. The Score for ZTS is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- ZTS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
Biomarin Pharmaceutical (BMRN)
is a Sell
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $70.69. The Score for BMRN is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- BMRN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ZTS Stock Price Chart
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $70.69
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight selling pressure.
ZTS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.12 | Buy |
| Relative Strength Index (14 RSI): | 60.68 | Buy |
| Chaikin Money Flow: | -328589 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (182.54 - 192.24) | Buy |
| Bollinger Bands (100): | (170.07 - 186.03) | Buy |
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.4 | Sell |
| Relative Strength Index (14 RSI): | 22.78 | Sell |
| Chaikin Money Flow: | -1009919 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (77.4 - 92.98) | Sell |
| Bollinger Bands (100): | (78.06 - 88.38) | Sell |
ZTS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 193.01 | Sell |
| 20-day SMA: | 188.39 | Buy |
| 50-day SMA: | 184.59 | Buy |
| 200-day SMA: | 180.03 | Buy |
| 8-day EMA: | 192.79 | Sell |
| 20-day EMA: | 189.74 | Buy |
| 50-day EMA: | 184.94 | Buy |
| 200-day EMA: | 178.74 | Buy |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 75.96 | Sell |
| 20-day SMA: | 83.55 | Sell |
| 50-day SMA: | 85.45 | Sell |
| 200-day SMA: | 86.8 | Sell |
| 8-day EMA: | 75.07 | Sell |
| 20-day EMA: | 80.72 | Sell |
| 50-day EMA: | 83.8 | Sell |
| 200-day EMA: | 85.86 | Sell |
Zoetis Earnings Growth & ZTS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.16 per share, an increase this year of $0.41 per share, and an increase next year of $0.63 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.29 per share, an increase this year of $1.19 per share, and an increase next year of $1.04 per share.
Zoetis Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biomarin Pharmaceutical Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||